Zika Virus Infection in a Cohort of Pregnant Women with Exanthematic Disease in Manaus, Brazilian Amazon
Elijane de Fátima Redivo,
Camila Bôtto Menezes,
Márcia da Costa Castilho,
Marianna Brock,
Evela da Silva Magno,
Maria das Graças Gomes Saraiva,
Salete Sara Alvarez Fernandes,
Anny Beatriz Costa Antony de Andrade,
Maria das Graças Costa Alecrim,
Flor Ernestina Martinez-Espinosa
Affiliations
Elijane de Fátima Redivo
Postgraduate Program in Tropical Medicine, University of Amazonas State, Manaus 69040-000, Brazil
Camila Bôtto Menezes
Postgraduate Program in Tropical Medicine, University of Amazonas State, Manaus 69040-000, Brazil
Márcia da Costa Castilho
Department of Virology, Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus 69040-000, Brazil
Marianna Brock
Department of Medicine, School of Health Sciences, University of Amazonas State, Manaus 69065-000, Brazil
Evela da Silva Magno
Department of Epidemiology and Public Health, Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus 69040-000, Brazil
Maria das Graças Gomes Saraiva
Department of Epidemiology and Public Health, Tropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus 69040-000, Brazil
Salete Sara Alvarez Fernandes
Postgraduate Program in Tropical Medicine, University of Amazonas State, Manaus 69040-000, Brazil
Anny Beatriz Costa Antony de Andrade
Postgraduate Program in Living Conditions and Health Situations in the Amazon PPGVIDA, Leônidas & Maria Deane Institute, Manaus 69057-070, Amazonas, Brazil
Maria das Graças Costa Alecrim
Postgraduate Program in Tropical Medicine, University of Amazonas State, Manaus 69040-000, Brazil
Flor Ernestina Martinez-Espinosa
Postgraduate Program in Tropical Medicine, University of Amazonas State, Manaus 69040-000, Brazil
The epidemic transmission of Zika virus (ZIKV) in Brazil has been identified as a cause of microcephaly and other neurological malformations in the babies of ZIKV-infected women. The frequency of adverse outcomes of Zika virus infection (ZIKVi) in pregnancy differs depending on the characteristics of exposure to infection, the time of recruitment of research participants, and the outcomes to be observed. This study provides a descriptive analysis—from the onset of symptoms to delivery—of a cohort registered as having maternal ZIKVi in pregnancy, from November 2015 to December 2016. Suspected cases were registered at a referral center for infectious and tropical diseases in Manaus, in the Amazonian region of Brazil. Of 834 women notified, 762 women with confirmed pregnancies were enrolled. Reverse-transcriptase polymerase chain reaction (RT-PCR) confirmed ZIKVi in 42.3% of the cohort. In 35.2% of the cohort, ZIKV was the sole infection identified. Severe adverse pregnancy outcomes (miscarriage, stillbirth, or microcephaly) were observed in both RT-PCR ZIKV-positive (5.0%) and ZIKV-negative (1.8%) cases (RR 3.1; 95% IC 1.4–7.3; p p < 0.001). Although other infectious rash diseases were observed in the pregnant women in the study, having confirmed maternal ZIKVi was the most important risk factor for serious adverse pregnancy events.